How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,003 results for

U.S. Preventive Services Task Force Recommendations

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Gui

and the prevention of sudden cardiac death. The executive summary contains mainly the recommendations. Glenn N. Levine, MD, FACC, FAHA Chair, ACC/AHA Task Force on Clinical Practice Guidelines 1. Introduction 1.1. Methodology and Evidence Review The recommendations listed in this clinical practice guideline are, whenever possible, evidence-based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLINE (through (...) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Gui 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search

2017 American Heart Association

2. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 (...) Estimulacion Cardiaca y Electrofisiologia. During final production review of the guidelines, several recommendations were refined to better reflect the data and current recommended medical practice. These refinements were reviewed and approved by the writing committee, the Task Force, and ACC, AHA, and HRS organizational leadership. These recommendations were: Section 7.1.1., recommendation 1 Section 7.1.3., recommendation 2 Section 7.2.1., recommendation 1 Section 7.9.1.4., recommendation 2 Section 10.8

2017 American Heart Association

3. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pract

Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pract Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death | Circulation Search Hello Guest! Login to your account Email Password Keep me logged (...) /AHA Task Force on Clinical Practice Guidelines (Task Force) modified its methodology. Evidence Review The Task Force recognizes the need for objective, independent evidence review committees (ERCs) that include methodologists, epidemiologists, clinicians, and biostatisticians who systematically survey, abstract, and assess the evidence to address systematic review questions posed in the PICOTS format ( P =population, I=intervention, C=comparator, O=outcome, T=timing, S=setting). , Practical

Full Text available with Trip Pro

2017 American Heart Association

4. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 (...) January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis A Scientific Statement From the American Heart Association and American College of Cardiology , MD, FACC, Chair , and MD, FACC MD, FACCon behalf

2015 American Heart Association

5. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 (...) February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome A Scientific Statement From the American Heart Association and American College

Full Text available with Trip Pro

2015 American Heart Association

6. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis

, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol . 2013 ; 61 :1527–1535. doi: 10.1016/j.jacc.2013.01.037. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis and Marfan syndrome. J Am Coll (...) Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis

2015 American Heart Association

7. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 (...) February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects A Scientific Statement From the American Heart Association and American College of Cardiology , MD

Full Text available with Trip Pro

2015 American Heart Association

8. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

may apply; see Appendix 1 for detailed information. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. ACC/AHA Representative. HRS Representative. ACEP and SAEM Joint Representative. ACC/AHA Task Force on Performance Measures Liaison. , Robert S. Sheldon , David G. Benditt Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Task Force on Clinical (...) on Performance Measures Liaison. , Mark S. Link Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. ACC/AHA Representative. HRS Representative. ACEP and SAEM Joint Representative. ACC/AHA Task Force on Performance Measures Liaison. , Brian Olshansky Writing committee members are required to recuse themselves from

2017 American Heart Association

9. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U?S? Department of Health and Human Services? Circulation? 2014;130:1662–7? 9? Nishimura RA, Otto CM, Bonow RO, et al? 2014 AHA/ACC guide- line for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiol- ogy/American Heart Association Task Force on Practice Guide- lines? Circulation? 2014;129 (...) , and 20% in patients whose surgery was performed at least 21 days after the neurological event. 286 Recommendations for IE Intervention (Continued) COR LOE Recommendations Comment/Rationale *Former Task Force member; current member during the writing effort? Downloaded from http://ahajournals.org by on March 27, 20192017 AHA/ACC VHD Focused Update Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1181 CLINICAL STATEMENTS AND GUIDELINES heart?org/statements by using

2017 American Heart Association

10. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer

Guidelines; 2010. American College of Cardiology and American Heart Association. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@ wcm/@sop/documents/downloadable/ucm_319826.pdf Accessed May 5, 2017. 5. Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification sys- tem: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133 (...) Task Force on Practice Guidelines. Circulation. 2014;130:e344–426. 65. Masson S, Anand I, Favero C, et al. Serial measurement of cardiac tro- ponin T using a highly sensitive assay in patients with chronic heart fail- ure: data from 2 large randomized clinical trials. Circulation. 2012;125: 280–8. 66. Savarese G, Musella F, D'Amore C, et al. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta- analysis. J Am Coll Cardiol HF. 2014;2:148–58. 67

2017 American Heart Association

11. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinic

guidelines in pa- tients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U .S . Department of Health and Human Services . Circulation . 2014;130:1662–7 . 8 . Halperin JL, Levine GN, Al-Khatib SM, et al . Further evolution of the ACC/AHA clinical practice guideline recommendation classi- fication system: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guide- lines (...) (ACC)/Ameri- can Heart Association (AHA) Task Force on Clinical Prac- tice Guidelines (“Task Force”) has issued this focused update to reassess guideline recommendations on the basis of recently published study data . This update has been subject to rigorous, multilevel review and approval, similar to the full guidelines . For specific focused update criteria and additional methodological details, please see the ACC/AHA guideline methodology manual . 1 Modernization Processes have evolved over time

Full Text available with Trip Pro

2016 American Heart Association

12. 2014 AHA/ACC Guideline for the Management of Patients With Non?ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

* ** Susan J. Zieman, MD, PhD, FACC† ACC/AHA TASK FORCE MEMBERS Jeffrey L. Anderson, MD, FACC, FAHA, Chair Jonathan L. Halperin, MD, FACC, FAHA, Chair-Elect Nancy M. Albert, PhD, RN, FAHA Judith S. Hochman, MD, FACC, FAHA†† Biykem Bozkurt, MD, PhD, FACC, FAHA Richard J. Kovacs, MD, FACC, FAHA Ralph G. Brindis, MD, MPH, MACC E. Magnus Ohman, MD, FACC Lesley H. Curtis, PhD, FAHA Susan J. Pressler, PhD, RN, FAHA David DeMets, PhD†† Frank W. Sellke, MD, FACC, FAHA Lee A. Fleisher, MD, FACC, FAHA Win-Kuang (...) at the point of care, the ACC/AHA Task Force on Practice Guidelines (Task Force) began modifying its methodology. This modernization effort is published in the 2012 Methodology Summit Report (3) and 2014 perspective article (4). The latter recounts the history of the collaboration, changes over time, current policies, and planned initiatives to meet the needs of an evolving healthcare environment. Recommendations on value in proportion to resource utilization will be incorporated as high-quality

2014 Society for Cardiovascular Angiography and Interventions

13. Recommendations for growth monitoring, prevention and management of overweight and obesity in children and youth in primary health care 2015

(Australia) (2013) 37 Lifestyle change including reduced energy intake and sedentary behaviour, increased physical activity and measures to support behavioural change. Note: CTFPHC = Canadian Task Force on Preventive Health Care, NICE = National Institute for Health and Care Excellence (UK), SIGN = Scottish Intercollegiate Guideline Network, USPSTF = U.S. Preventive Services Task Force.Guidelines 420 CMAJ, April 7, 2015, 187(6) unable to recommend specific interventions because we only examined (...) in children and youth aged 2 to 17 years. Methods The Canadian Task Force on Preventive Health Care is an independent panel of clinicians and methodologists that makes recommendations about clinical manoeuvres aimed at primary and secondary prevention (www.canadiantaskforce .ca). Work on each set of recommendations is led by a workgroup of two to six members of the task force. Each workgroup establishes the research questions and analytical framework for the guide- line, which are incorporated

2015 CPG Infobase

14. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations.

of thrombotic risk, especially when newly implanted ( x 18 Dangas, G.D., Weitz, J.I., Giustino, G., Makkar, R., and Mehran, R. Prosthetic heart valve thrombosis. J Am Coll Cardiol . 2016 ; 68 : 2670–2689 ) (18) . Coronary Artery Disease As discussed in part I of these guidelines, significant morbidity and potential for thromboembolic complications exist if such patients are mismanaged ( x 20 Windecker, S., Kolh, P., Alfonso, F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force (...) in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol . 2017 ; 69 : 871–898 ) (3) . In a study examining 1,293 incidents of warfarin interruption in 1,024 patients ( x 23 Garcia, D.A., Regan, S., Henault, L.E. et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med . 2008 ; 168 : 63–69 ) (23) , the most common indications for anticoagulation were atrial

Full Text available with Trip Pro

2019 Society of Interventional Radiology

15. Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update: A Policy Statement From the American Stroke Association

. Clinicians, policymakers, and numerous courageous stroke survivors play a key role in supporting the “pyramid base” by promoting programs that prevent the emergence of risk factors for developing disease. The 2005 AHA/ASA recommendations for the stroke systems of care task force listed primordial/primary stroke prevention as 1 of 7 required elements of an organized stroke system. The 2013 AHA/ASA policy statement on interactions with stroke systems of care included the recommendation that health (...) to help guide policymakers and public healthcare agencies in continually updating their stroke systems of care in light of these changes. This statement and its recommendations span primordial and primary prevention, acute stroke recognition and activation of emergency medical services, triage to appropriate facilities, designation of and treatment at stroke centers, secondary prevention at hospital discharge, and rehabilitation and recovery. To translate advances in scientific knowledge

Full Text available with Trip Pro

2019 American Heart Association

16. Recommendations on screening for breast cancer in women 40-74 years of age who are not at increased risk

topic: spotlight on benefits and harms. Results report: January 2011–December 2012 . Toronto : Canadian Partnership Against Cancer ; 2017 . Independent UK Panel of Breast Cancer Screening . The benefits and harms of breast cancer screening: an independent review . Fitzpatrick-Lewis D , Hodgson N , Ciliska D , et al . Breast cancer screening . Hamilton (ON) : McMaster University ; 2011 . Tonelli M , Connor Gorber S , Joffres M ; Canadian Task Force on Preventive Health Care . Recommendations (...) Health Care under contract by the Public Health Agency of Canada). CTFPHC ; 2017 . Available: ( accessed 2017 Oct. 9 ). Nelson HD , Fu R , Cantor A , et al . Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation . Duke Evidence Synthesis Group . Systematic review of cancer screening literature for updating American Cancer Society breast cancer screening guidelines . Atlanta : American Cancer Society ; 2014

2018 Canadian Task Force on Preventive Health Care

17. Suicide Prevention Interventions and Referral/Follow-up Services

on this evidence report are welcome and can be sent to Nicole Floyd, ESP Coordinating Center Program Manager, at nicole.floyd@va.gov. Recommended citation: O’Neil ME, Peterson K, Low A, Carson S, Denneson LM, Haney E, Shiroma P and Kansagara D. Suicide Prevention Interventions and Referral/Follow-up Services: A Systematic Review. VA-ESP Project #05-225; 2012. This report is based on research conducted by the Evidence-based Synthesis Program (ESP) Center located at the Portland VA Medical Center, Portland (...) services conducted outside of Veteran or military settings that can be applied to Veteran and/or military populations? 27 SUMMARY AND DISCUSSION 31 Limitations 33 Recommendations for Future Research 33 Conclusions 34 REFERENCES 36 FIGURES Figure 1. Suicide Prevention Analytical Model 9 Figure 2. Literature Flow Chart 15iii Suicide Prevention Interventions and Referral/Follow-up Services: A Systematic Review Evidence-based Synthesis Program APPENDIX A. SEARCH STRA TEGIES 46 APPENDIX B. STUDY SELECTION

2012 Veterans Affairs Evidence-based Synthesis Program Reports

18. WHO recommendations: intrapartum care for a positive childbirth experience

ages. One of the WHO strategic priorities over the next five years for achieving Sustainable Development Goal (SDG) targets is to support countries to strengthen their health systems to fast-track progress towards achieving universal health coverage (UHC). WHO is supporting countries to ensure that all people and communities have access to and can use the promotive, preventive and curative health services that are appropriate to their needs, and that are effective and of sufficient quality, while (...) not exposing them to financial hardship. An integral part of these efforts is the design of the package of essential services across the spectrum of health disciplines, including reproductive, maternal, newborn, child and adolescent health, from which a set of basic service-delivery indicators can be identified for use in monitoring countries’ progress towards UHC. This guideline is a consolidated set of new and existing recommendations on essential labour and childbirth practices that should be provided

2018 World Health Organisation Guidelines

19. 2018 EHRA Expert Consensus Statement on Lead Extraction: Recommendations on Definitions, Endpoints, Research Trial Design, and Data Collection Requirements for Clinical Scientific Studies and Registries: Endorsed by APHRS/HRS/LAHRS

Recommendations • Trial design • Registry • Training • EHRA consensus statement * Corresponding author. Tel:þ39 50 993043; fax:þ39 50 995329. E-mail address: m.g.bongiorni@med.unipi.it Published on behalf of the European Society of Cardiology. All rights reserved.V C The Author(s) 2018. For permissions, please email: journals.permissions@oup.com. Europace (2018)00, 1–11 EHRACONSENSUSSTATEMENT doi:10.1093/europace/euy050 Downloaded from https://academic.oup.com/europace/advance-article-abstract/doi/10.1093 (...) Expert Consensus Statement on CIED lead management and extraction. Heart Rhythm 2017;14:e503–51. 7. Deharo JC, Bongiorni MG, Rozkovec A, Bracke F, Defaye P, Fernandez-Lozano I et al. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper. Europace 2012;14:124–34. 8. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force

2018 Heart Rhythm Society

20. AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement

/STS staff. A public comment period was held to obtain further feedback. Following reconciliation of all comments and sign-off by the writing committee and oversight task force, this document was approved for publication by the approval bodies of the partnering societies. Bavaria JE, et al. TAVR Recommendations and Requirements 19 3. Structural Program Requirements The structural measures of quality include the requirement that operators and institutions have the skills, experience, foundational (...) AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement Bavaria JE, et al. TAVR Recommendations and Requirements 1 MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement A Joint Report of the American Association

2018 Society for Cardiovascular Angiography and Interventions

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>